-
The effect of radiotherapy on patients with advanced HL who have been treated with the ABVD regimen and have large mass lesions: the final results of the FIL HD0801 study are announced
Time of Update: 2021-12-08
In the third phase of the study, patients who achieved CMR after 2 and 6 cycles of ABVD treatment and had large mass lesions (maximum diameter ≥5cm) were randomly assigned to receive consolidation radiotherapy (dose 30Gy) or observation (OBS) .
-
Science Sub-Journal: Environment + MEF2 transcription factor is related to the "cognitive flexibility" of the elderly
Time of Update: 2021-11-11
A new study by researchers at the Massachusetts Institute of Technology (MIT) shows that this environment appears to activate a gene family called MEF2, which controls genetic programs in the brain that promote resistance to cognitive decline .
-
NEJM: REGEN-COV can effectively reduce the risk of subsequent illness in close contacts of new coronary pneumonia
Time of Update: 2021-09-29
Among the close family contacts of patients with new coronary pneumonia, subcutaneous injection of REGEN-COV can effectively reduce the risk of infection.
Among the close family contacts of patients with new coronary pneumonia, subcutaneous injection of REGEN-COV can effectively reduce the risk of infection.
-
Better than the second-line standard treatment CAR-T therapy to reach the phase 3 clinical primary endpoint
Time of Update: 2021-06-16
Bristol-Myers Squibb Company (BMS) today announced that its CD19-targeted CAR-T cell therapy Breyanzi (lisocabtagene maraleucel) has reached the primary and key secondary endpoints in a phase 3 clinical trial, significantly improving recurrence compared with standard treatment /Event-free survival, complete remission rate and progression-free survival of patients with refractory large B-cell lymphoma (LBCL) .
-
Chinese scientists have revealed the neural mechanisms of the visual crowding effect
Time of Update: 2021-02-25
, using group-sensing field technology based on functional magnetic resonance imaging, Professor Fang Fang of Peking University's School of Psychology and Cognitive Sciences revealed the neural mechanism of visual crowding effect.
-
Cancer Sci: Scientists hope to develop a targeted treatment for many types of cancer - "α-ray missile therapy
Time of Update: 2021-01-18
researcher Professor Kazuko Kaneda-Nakashima said: 'We found that 211At-labeled α-methyl-L tyrosine (211At-AAMT) has a high affinity for LAT1, which effectively inhibits tumor cells and promotes DNA double-stranded fragmentation in-body.
-
The cause of hearing loss caused by the anti-cancer drug cisplatin was identified
Time of Update: 2020-12-15
In a paper published the journal Psychic, the researchers said cisplatin build-up in the inner ear, especially in cochlear implant lines, is a direct cause of hearing loss in patients.
-
ROCK2 inhibitors are eligible for FDA priority review to help re-establish immune balance
Time of Update: 2020-12-13
mechanism of effects of rock2 inhibitors (Photo source: Resources) The submission of NDA was supported by positive data from ROCKstar (KD025-213), a critical study in which patients with cGVHD who had received at least 2 systemic treatments were involved and were randomly grouped into different doses of belumosudil.
-
The story of a new generation of headache drugs, CGRP-targeted drugs
Time of Update: 2020-11-11
, CGRP targeted drugs used to treat acute migraine attacks appear to cause only minor side effects such as constipation in a small number of people.
, for example, CGRP antibodies are used to prevent migraine attacks, gepant is used to treat acute seizures, is there a drug that can balance two effects?
-
Latest recommendations for the use of steroid hormones in the treatment of adult brain metastatic tumors
Time of Update: 2020-06-03
Timothy C Ryken of Dartmouth-Hitchcock Medical Center in New Hampshire, USA, wrote the recommendations of the American Association of Neurosurgeons (Congress of Neurosurgeon, CNS) on the systematic re
-
Milepost! Epidyolex, the first plant-based cannabinoid drug, has been approved by the European Union for the treatment of two rare pediatric epilepsy
Time of Update: 2019-09-24
September 24, 2019 / BIOON / - GW Pharma, a British pharmaceutical company, is a global leader in the research and development of plant-based cannabinoid treatment products, committed to the discovery
-
China's first original anti AI new drug iconine ® is on the market
Time of Update: 2018-09-03
On September 2, 2018, the global launch conference of the world's first long-acting HIV-1 fusion inhibitor, ibovetai (aikonin ®), developed by China's innovative biomedical enterprise frontier biophar
-
Imatinib can save 100000 US dollars in 5 years for patients with expired patent of anticancer drug Gleevec
Time of Update: 2016-03-18
Source: www.qiaobao.com.cn on March 18, 2016, scientists from Johns Hopkins University in the United States said that if the anticancer drug gleevac was replaced by imatinib, it could save 100000 doll
-
Why can the biopharmaceutical company raise $300 million in 12 months
Time of Update: 2014-08-08
Source: ft Chinanet 2014-08-08 Juno therapeutics has long been one of the most fundraising start-ups in the history of biotechnology development, and the company just announced that it has raised $134
